Search Results
May 14, 2026, 12:18 ET CPSC Posts Product Recalls to its Web Site
World Bright International Limited Recalls Agio Menlo Woven Patio Swings Due to Risk of Serious Injury or Death from Fall Hazard; Sold at Costco | CPSC.gov
More news about: U.S. Consumer Product Safety Commission
Apr 01, 2026, 09:00 ET Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky
Levi & Korsinsky notifies investors that it has commenced an investigation of Agios Pharmaceuticals, Inc. ("Agios Pharmaceuticals, Inc.") (NASDAQ: AGIO) concerning possible violations of federal securities laws.
More news about: Levi & Korsinsky, LLP
Mar 31, 2026, 09:00 ET AGIO ALERT- The Gross Law Firm Has Commenced an Investigation on Behalf of Agios Pharmaceuticals, Inc. Shareholders Who Lost Money
fraud claims on behalf of certain Agios Pharmaceuticals, Inc. investors. If you incurred a loss on your AGIO investment, please contact us using the link below to discuss your rights.
More news about: The Gross Law Firm
Mar 25, 2026, 09:00 ET AGIO STOCK ALERT: Levi & Korsinsky Notifies Agios Pharmaceuticals, Inc. Investors of an Ongoing Investigation
Levi & Korsinsky notifies investors that it has commenced an investigation of Agios Pharmaceuticals, Inc. ("Agios Pharmaceuticals, Inc.") (NASDAQ: AGIO) concerning possible violations of federal securities laws.
More news about: Levi & Korsinsky, LLP
Mar 24, 2026, 09:00 ET The Gross Law Firm Announces an Investigation on Behalf of Agios Pharmaceuticals, Inc. (AGIO) Shareholders Who May Have Been Affected by Fraud
investigating potential securities fraud claims on behalf of certain Agios Pharmaceuticals, Inc. investors. If you incurred a loss on your AGIO investment, please contact us using the link below to discuss your rights.
More news about: The Gross Law Firm
Mar 18, 2026, 09:00 ET ATTENTION AGIO SHAREHOLDERS: Investors who lost money on Agios Pharmaceuticals, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
Levi & Korsinsky notifies investors that it has commenced an investigation of Agios Pharmaceuticals, Inc. ("Agios Pharmaceuticals, Inc.") (NASDAQ: AGIO) concerning possible violations of federal securities laws.
More news about: Levi & Korsinsky, LLP
Mar 17, 2026, 09:00 ET Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? Contact The Gross Law Firm Regarding an Ongoing Investigation
investigating potential securities fraud claims on behalf of certain Agios Pharmaceuticals, Inc. investors. If you incurred a loss on your AGIO investment, please contact us using the link below to discuss your rights.
More news about: The Gross Law Firm
Mar 11, 2026, 09:00 ET Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
Levi & Korsinsky notifies investors that it has commenced an investigation of Agios Pharmaceuticals, Inc. ("Agios Pharmaceuticals, Inc.") (NASDAQ: AGIO) concerning possible violations of federal securities laws.
More news about: Levi & Korsinsky, LLP
Mar 10, 2026, 09:00 ET Agios Pharmaceuticals, Inc. Investigated Regarding Potential Securities Law Violations - Contact The Gross Law Firm for Details- AGIO
investigating potential securities fraud claims on behalf of certain Agios Pharmaceuticals, Inc. investors. If you incurred a loss on your AGIO investment, please contact us using the link below to discuss your rights.
More news about: The Gross Law Firm
Mar 04, 2026, 09:00 ET Levi & Korsinsky Reminds Agios Pharmaceuticals, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - AGIO
Levi & Korsinsky notifies investors that it has commenced an investigation of Agios Pharmaceuticals, Inc. ("Agios Pharmaceuticals, Inc.") (NASDAQ: AGIO) concerning possible violations of federal securities laws.
More news about: Levi & Korsinsky, LLP
Mar 03, 2026, 09:00 ET Agios Pharmaceuticals, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact The Gross Law Firm Regarding Potential Securities Law Violations - AGIO
potential securities fraud claims on behalf of certain Agios Pharmaceuticals, Inc. investors. If you incurred a loss on your AGIO investment, please contact us using the link below to discuss your rights.
More news about: The Gross Law Firm
Feb 17, 2026, 09:17 ET Netrio Expands Belfast Office to Further International Growth
our people, customers and partners."Netrio's presence in Belfast originated with the company's acquisition of Agio, a New York City-based managed service provider, in May 2025. Agio established its Belfast office in 2020, and the local team plays a pivotal role in the ongoing development and support
More news about: Netrio
Jan 12, 2026, 09:18 ET Netrio Opens a New India Office in the Next Phase of Its Global Expansion
currently operates U.S. offices in McKinney, Texas (near Dallas); Buffalo, New York; New York City; and Minneapolis. Through its May 2025 acquisition of Agio, the company added its first international office in Belfast, Northern Ireland, in addition to a remote team of individuals in India that would become
More news about: Netrio
Nov 24, 2025, 05:13 ET Creare il Natale insieme: UGREEN dà energia ai momenti che definiscono la stagione delle feste
semplici e accessibili a tutte le generazioni. Oltre il 95% degli utenti ne ha elogiato la facilità d'uso e perfino i nonni possono sentirsi a proprio agio.Per le coppie, il MagFlow Magnetic Power Bank da 10.000 mAh e 25 W è un modo piccolo, ma pratico, per dimostrare il proprio affetto. Mantiene
More news about: UGREEN Limited
Nov 14, 2025, 07:30 ET Invictus Pharmacy è la prima ad accettare criptovalute per le prescrizioni
Maggiore accessibilità: accettare le criptovalute apre l'accesso ai servizi farmaceutici anche ai più giovani che preferiscono o si sentono a loro agio nell'utilizzare le valute digitali. Trasparenza: ogni transazione viene registrata sulla blockchain,
More news about: Invictus Pharmacy
Oct 18, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. ("Agios" or the "Company") (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,
More news about: Pomerantz LLP
Oct 13, 2025, 13:42 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. ("Agios" or the "Company") (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Oct 13, 2025, 10:25 ET GTCR Announces Promotions and New Team Appointments Across the Organization
Prior to joining GTCR, Miten was Managing Director at Blue Owl Capital and Senior Vice President at Blackstone. Previously, Miten spent 11 years with Agio, a managed IT and Cybersecurity services company he co-founded in 2010. Miten holds a BS in Computer Science from Rutgers University.
More news about: GTCR
Oct 08, 2025, 17:44 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. ("Agios" or the "Company") (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Oct 03, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. ("Agios" or the "Company") (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,
More news about: Pomerantz LLP
Sep 29, 2025, 03:19 ET Dun & Bradstreet celebrates three decades of supporting MSMEs in India
Agio Pharmaceuticals Limited
More news about: Dun & Bradstreet India
Sep 28, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. ("Agios" or the "Company") (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,
More news about: Pomerantz LLP
Sep 23, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. ("Agios" or the "Company") (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at [email protected]
More news about: Pomerantz LLP
Sep 22, 2025, 12:00 ET Netrio Launches Next Release of NetrioNow to Reinvent Managed Services and Redefine the Customer Experience Industry-wide
collaboration with AI and automation – delivering speed, transparency, and outcomes that matter to customers. "NetrioNow is a game-changer. The Agio team invested tremendous effort and expertise in developing and refining the AgioNow platform, and the customer response and adoption has reflected
More news about: Netrio
Sep 18, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. ("Agios" or the "Company") (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at [email protected]
More news about: Pomerantz LLP